Mass Spectrometric Quantitation of Pyridyloxobutyl DNA Phosphate Adducts in Rats Chronically Treated with N'-Nitrosonornicotine.

The tobacco-specific carcinogens N'-nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) require metabolic activation to exert their carcinogenicity. NNN and NNK are metabolized to the same reactive diazonium ions, which alkylate DNA forming pyridyloxobutyl (POB) DNA base and phosphate adducts. We have characterized the formation of both POB DNA base and phosphate adducts in NNK-treated rats and the formation of POB DNA base adducts in NNN-treated rats. However, POB DNA phosphate adducts in NNN-treated rats are still uncharacterized. In this study, we quantified the levels of POB DNA phosphate adducts in tissues of rats chronically treated with ( S)-NNN or ( R)-NNN for 10, 30, 50, and 70 weeks during a carcinogenicity study. The highest amounts of POB DNA phosphate adducts were observed in the esophagus of the ( S)-NNN-treated rats, with a maximum level of 5400 ± 317 fmol/mg DNA at 50 weeks. The abundance of POB DNA phosphate adducts in the esophagus was consistent with the results of the carcinogenicity study showing that the esophagus was the primary site of tumor formation from treatment with ( S)-NNN. Compared to the ( R)-NNN group, the levels of POB DNA phosphate adducts were higher in the oral mucosa, esophagus, and liver, while lower in the nasal mucosa of the ( S)-NNN-treated rats. Among 10 combinations of all isomers of POB DNA phosphate adducts, Ap(POB)C and combinations with thymidine predominated across all the rat tissues examined. In the primary target tissue, esophageal mucosa, Ap(POB)C accounted for ∼20% of total phosphate adducts in the ( S)-NNN treatment group throughout the 70 weeks, with levels ranging from 780 ± 194 to 1010 ± 700 fmol/mg DNA. The results of this study showed that POB DNA phosphate adducts were present in high levels and persisted in target tissues of rats chronically treated with ( S)- or ( R)-NNN. These results improve our understanding of DNA damage during NNN-induced carcinogenesis. The predominant POB DNA phosphate isomers observed, such as Ap(POB)C, may serve as biomarkers for monitoring chronic exposure of tobacco-specific nitrosamines in humans.

[1]  Yinsheng Wang,et al.  Cytotoxic and mutagenic properties of alkyl phosphotriester lesions in Escherichia coli cells , 2018, Nucleic acids research.

[2]  S. Hecht,et al.  Identification of more than 100 structurally unique DNA-phosphate adducts formed during rat lung carcinogenesis by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone , 2018, Carcinogenesis.

[3]  S. Hecht,et al.  Methyl DNA Phosphate Adduct Formation in Rats Treated Chronically with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol , 2017, Chemical research in toxicology.

[4]  S. Hecht,et al.  Pyridylhydroxybutyl and pyridyloxobutyl DNA phosphate adduct formation in rats treated chronically with enantiomers of the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol , 2017, Mutagenesis.

[5]  S. Hecht,et al.  DNA Adduct Formation from Metabolic 5'-Hydroxylation of the Tobacco-Specific Carcinogen N'-Nitrosonornicotine in Human Enzyme Systems and in Rats. , 2016, Chemical research in toxicology.

[6]  S. Hecht,et al.  Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines. , 2016, Accounts of chemical research.

[7]  S. Hecht,et al.  Analysis of O(6)-[4-(3-Pyridyl)-4-oxobut-1-yl]-2'-deoxyguanosine and Other DNA Adducts in Rats Treated with Enantiomeric or Racemic N'-Nitrosonornicotine. , 2016, Chemical research in toxicology.

[8]  Delshanee Kotandeniya,et al.  Comprehensive High-Resolution Mass Spectrometric Analysis of DNA Phosphate Adducts Formed by the Tobacco-Specific Lung Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone , 2015, Chemical research in toxicology.

[9]  S. Hecht,et al.  Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats. , 2014, Carcinogenesis.

[10]  S. Hecht,et al.  Quantitation of pyridyloxobutyl-DNA adducts in tissues of rats treated chronically with (R)- or (S)-N'-nitrosonornicotine (NNN) in a carcinogenicity study. , 2013, Chemical research in toxicology.

[11]  S. Hecht,et al.  (S)-N'-Nitrosonornicotine, a constituent of smokeless tobacco, is a powerful oral cavity carcinogen in rats. , 2013, Carcinogenesis.

[12]  S. Hecht,et al.  Levels of (S)-N'-nitrosonornicotine in U.S. tobacco products. , 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[13]  Jian-Min Yuan,et al.  Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers. , 2011, Carcinogenesis.

[14]  P. Farmer,et al.  Phosphotriester adducts (PTEs): DNA's overlooked lesion. , 2010, Mutagenesis.

[15]  B. Lindgren,et al.  Comparative Levels of O6-Methylguanine, Pyridyloxobutyl-, and Pyridylhydroxybutyl-DNA Adducts in Lung and Liver of Rats Treated Chronically with the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone , 2009, Drug Metabolism and Disposition.

[16]  B. Lindgren,et al.  Quantitation of pyridyloxobutyl DNA adducts in nasal and oral mucosa of rats treated chronically with enantiomers of N'-nitrosonornicotine. , 2009, Chemical research in toxicology.

[17]  S. Hecht,et al.  Analysis of pyridyloxobutyl DNA adducts in F344 rats chronically treated with (R)- and (S)-N'-nitrosonornicotine. , 2007, Chemical research in toxicology.

[18]  Iarc Monographs,et al.  Smokeless tobacco and some tobacco-specific N-nitrosamines. , 2007, IARC monographs on the evaluation of carcinogenic risks to humans.

[19]  A. Pegg,et al.  O6-pyridyloxobutylguanine adducts contribute to the mutagenic properties of pyridyloxobutylating agents. , 2005, Chemical research in toxicology.

[20]  B. Walther,et al.  CHARACTERIZATION OF MICROSOMAL CYTOCHROME P450-DEPENDENT MONOOXYGENASES IN THE RAT OLFACTORY MUCOSA , 2005, Drug Metabolism and Disposition.

[21]  S. Hecht,et al.  Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine. , 2005, Chemical research in toxicology.

[22]  P. Farmer,et al.  Further development of 32P-postlabeling for the detection of alkylphosphotriesters: evidence for the long-term nonrandom persistence of ethyl-phosphotriester adducts in vivo. , 2004, Chemical research in toxicology.

[23]  Stephen S. Hecht,et al.  Tobacco carcinogens, their biomarkers and tobacco-induced cancer , 2003, Nature Reviews Cancer.

[24]  S. Murphy,et al.  Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[25]  L. Reha-Krantz,et al.  Differences in replication of a DNA template containing an ethyl phosphotriester by T4 DNA polymerase and Escherichia coli DNA polymerase I. , 2003, Nucleic acids research.

[26]  S. Hecht,et al.  Metabolism and pharmacokinetics of N'-nitrosonornicotine in the patas monkey. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[27]  R. Moschel,et al.  Mutagenesis by O6-[4-Oxo-4-(3-pyridyl)butyl]guanine in Escherichia coli and Human Cells , 2002 .

[28]  S. Hecht,et al.  Enantiomeric composition of N'-nitrosonornicotine and N'-nitrosoanatabine in tobacco. , 2000, Carcinogenesis.

[29]  C. Weghorst,et al.  Expression of cytochrome P450 2A3 in rat esophagus: relevance to N-nitrosobenzylmethylamine. , 1999, Carcinogenesis.

[30]  S. Hecht,et al.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.

[31]  A. Dahl,et al.  Metabolic capacity of nasal tissue interspecies comparisons of xenobiotic-metabolizing enzymes. , 1997, Mutation research.

[32]  C. S. Yang,et al.  Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes. , 1997, Carcinogenesis.

[33]  J. Nair,et al.  Metabolism of N′‐nitrosonornicotine by adult and fetal human oesophagal cultures , 1995, Cell biology international.

[34]  S. Murphy,et al.  Comparative metabolism of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured F344 rat oral tissue and esophagus. , 1990, Cancer research.

[35]  A. Tates,et al.  Formation and stability of alkylated pyrimidines and purines (including imidazole ring-opened 7-alkylguanine) and alkylphosphotriesters in liver DNA of adult rats treated with ethylnitrosourea or dimethylnitrosamine. , 1986, Carcinogenesis.

[36]  A. Drake,et al.  Stereospecific removal of methyl phosphotriesters from DNA by an Escherichia coli ada+ extract. , 1985, Nucleic acids research.

[37]  T. Lindahl,et al.  Methyl phosphotriesters in alkylated DNA are repaired by the Ada regulatory protein of E. coli. , 1985, Nucleic acids research.

[38]  S. Hecht,et al.  Metabolism of tobacco-specific N-nitrosamines by cultured human tissues. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Hecht,et al.  Metabolism of tobacco-specific nitrosamines by cultured rat nasal mucosa. , 1983, Cancer research.

[40]  E. Brittebo,et al.  Localization and binding of N'-nitrosonornicotine metabolites in the nasal region and in some other tissues of Sprague-Dawley rats. , 1982, Cancer research.

[41]  G. Williams,et al.  Metabolism of N'-nitrosonornicotine by cultured rat esophagus. , 1982, Carcinogenesis.

[42]  J. Cleaver,et al.  Evidence for removal at different rates of O-ethyl pyrimidines and ethylphosphotriesters in two human fibroblast cell lines. , 1979, Nucleic acids research.

[43]  S. Hecht,et al.  Alpha-hydroxylation of N-nitrosopyrrolidine and N'-nitrosonornicotine by human liver microsomes. , 1979, Cancer Letters.

[44]  K. V. Shooter,et al.  The stability of methyl and ethyl phosphotriesters in DNA in vivo. , 1977, Chemico-biological interactions.